Background: Gaps exist in our understanding of the clinical course of pouch-related disorders. Methods: We evaluated baseline disease activity and longitudinal treatment patterns among patients with inflammatory conditions of the pouch. Results: Among 468 patients with an ileal pouch-anal anastomosis (IPAA), 94 (20%) had acute pouchitis, 96 (21%) had chronic pouchitis, and 192 (41%) had Crohn disease of the pouch. Following an IPAA, 38% of patients were treated with a biologic and 11% underwent inflammatory bowel disease- or bowel-related surgery. Conclusions: Treatment patterns after IPAA indicate that pouch-related disorders have a significant impact on individual patients and the healthcare system. Lay summary In a multicenter longitudinal cohort from 7 academic centers, a significant burden of inflammatory conditions of the pouch was demonstrated after restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis.
|Original language||English (US)|
|Number of pages||8|
|Journal||Crohn's and Colitis 360|
|State||Published - Jul 1 2020|
- Biologic therapy
- Ileal pouch-anal anastomosis
ASJC Scopus subject areas